Rivaroxaban is an oral anticoagulant medication commonly prescribed to prevent and treat blood clots, including deep vein thrombosis and stroke in patients with atrial fibrillation. Unlike traditional blood thinners, Rivaroxaban directly inhibits Factor Xa, a key enzyme in the coagulation cascade, providing effective anticoagulation with a fixed dosing regimen and no routine monitoring. Ensuring the pharmaceutical purity of Rivaroxaban is essential for patient safety, optimal therapeutic outcomes, and regulatory adherence. Impurity profiling is vital to detect and control any unwanted substances formed during manufacturing or storage.
Showing 1 - 1 of 1 products
